Literature DB >> 2176818

The effect of cyclic AMP on the growth of Toxoplasma gondii in vitro.

W Y Choi1, H W Nam, J H Youn, D J Kim, W K Kim, W S Kim.   

Abstract

To assess the role of cAMP on the growth and proliferation of Toxoplasma in HL-60 cells we tested the effect of exogenous cAMP and cAMP analogues to the co-culture system of Toxoplasma and HL-60 cells. cAMP, dbcAMP, and br-cAMP stimulated the growth of Toxoplasma at a specific concentration, i.e., 10(0) mM, 10(0) mM, and 10(-1) mM, respectively. There were differences in growth induction kinetics and in the rate of promotion. These results were further verified by treating the co-culture with adenylate cyclase activator, pNHppG, cAMP phosphodiesterase activators, imidazole and A23187, and cAMP phosphodiesterase inhibitors, IBMX, compound 48/80, and theophylline, separately. When the cytosolic cAMP levels increased by the reagents mentioned above, Toxoplasma in the cytoplasm of HL-60 cells stimulated to proliferate more rapidly with concentration-dependent modes compared to the control, and vice versa. It is suggested that some mechanisms are activated by the high levels of cAMP in the cytoplasm, which result in the stimulation of Toxoplasma proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176818     DOI: 10.3347/kjp.1990.28.2.71

Source DB:  PubMed          Journal:  Kisaengchunghak Chapchi


  3 in total

1.  Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii.

Authors:  Michael S Eaton; Louis M Weiss; Kami Kim
Journal:  Int J Parasitol       Date:  2005-09-22       Impact factor: 3.981

Review 2.  PKA and Apicomplexan Parasite Diseases.

Authors:  M Haidar; G Ramdani; E J Kennedy; G Langsley
Journal:  Horm Metab Res       Date:  2016-11-11       Impact factor: 2.936

Review 3.  Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.

Authors:  C J Carter
Journal:  Schizophr Bull       Date:  2008-06-13       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.